Dividends & Buybacks ·
At its July 17, 2026 Annual Meeting, Picard Medical, Inc. stockholders approved several material charter amendments
PMIPicard Medical, Inc.
At its July 17, 2026 Annual Meeting, Picard Medical, Inc. stockholders approved several material charter amendments. The company is now authorized to execute a reverse stock split at a ratio between 1-for-15 and 1-for-50, with the final ratio and timing to be determined by the Board of Directors. Additionally, stockholders approved the designation of Class B common stock, which carries 20 votes per share. Other approved items included the election of directors Richard Fang, Sam Van, Joe Xiao, and George Ye, the ratification of MaloneBailey LLP as the 2026 independent auditor, and an annual frequency for advisory votes on executive compensation. The company operates in the medical industry and provides healthcare-related products or services.